China must admit to massive crackdown on Muslims in Xinjiang: Amnesty

Agencies
September 24, 2018

Beijing, Sept 24: China must come clean about the fate of an estimated one million minority Muslims swept up in a "massive crackdown" in the far western region of Xinjiang, Amnesty International said in a new report on Monday.

Beijing has ramped up restrictions on Muslim minorities to combat what it calls Islamic extremism and separatist elements in the far western province. But critics say the drive risks fuelling resentment towards Beijing and further inflaming separatist sentiment.

In a new report, which included testimony from people held in the camps, Amnesty said Beijing had rolled out "an intensifying government campaign of mass internment, intrusive surveillance, political indoctrination and forced cultural assimilation". Uighurs and other Muslim minorities are punished for violating regulations banning beards and burqas, and for the possession of unauthorised Korans, it added.

Up to a million people are detained in internment camps, a United Nations panel on racial discrimination reported last month, with many interned for offences as minor as making contact with family members outside the country or sharing Islamic holiday greetings on social media.

"Hundreds of thousands of families have been torn apart by this massive crackdown," said Nicholas Bequelin, Amnesty International's East Asia director in a statement. "They are desperate to know what has happened to their loved ones and it is time the Chinese authorities give them answers."

Beijing has denied reports of the camps but the evidence is mounting in the form of government documents and escapee testimony. It suggests Chinese authorities are detaining large groups of people in a network of extrajudicial camps for political and cultural indoctrination on a scale unseen since the Maoist era.

Amnesty's report interviewed several former detainees who said they were put in shackles, tortured, and made to sing political songs and learn about the Communist Party. The testimony tallies with similar evidence gathered by foreign reporters and rights groups in the last year.

Amnesty also called on governments around to world to hold Beijing to account for "the nightmare" unfolding in Xinjiang. Last week, US Secretary of State Mike Pompeo denounced "awful abuses" of Uighur Muslim detained in re-education camps.

China's top leaders recently called for religious practices to be brought in line with "traditional" Chinese values and culture, sparking concern among rights groups. Earlier this month, draft regulations suggested that Beijing was considering restrictions on religious content online, such as images of people praying or chanting.

State supervision of religion has increased in a bid to "block extremism", and authorities have removed Islamic symbols such as crescents from public spaces in areas with significant Muslim populations.

Christians have also been targeted in crackdowns, with a prominent Beijing "underground" church shuttered by authorities earlier this month, while churches in central Henan province have seen their crosses torn down and followers harassed.

Comments

ABDUL AZIZ
 - 
Monday, 24 Sep 2018

Better stop to do with muslims and human beings. , or else , wait for ALLAH,S wrath  soon.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 20,2020

Paris, Jul 20: Two coronavirus vaccine candidates have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors said on Monday.

The first trial among more than 1,000 adults in Britain found that the vaccine induced "strong antibody and T cell immune responses" against the novel coronavirus.

A separate trial in China involving more than 500 people showed most had developed widespread antibody immune response.

The studies, published in The Lancet medical journal, constitute a major step on the road towards a COVID-19 vaccine that is effective and safe for widespread use.

The authors of the studies said that they encountered few adverse side-effects from the vaccine candidates.

However, they cautioned that more research was needed, particularly among older adults, who are disproportionately at risk of dying of COVID-19.

Co-author Sarah Gilbert from the University of Oxford said the results "hold promise".

"If our vaccine is effective, it is a promising option as these types of vaccine can be manufactured at large scale."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 19,2020

Moscow, May 19: Russia confirmed 9,263 new coronavirus infections Tuesday, bringing the country’s official number of cases to 299,941.

On Sunday, the head of Russia's public health watchdog, Anna Popova, said the growth of new coronavirus cases in Russia is stabilizing.

Russia is the second most-affected country in terms of infections.

A record 115 people have died over the past 24 hours, bringing the total toll to 2,837 — a rate considerably lower than in many other countries hit hard by the pandemic.

Russia began easing nation-wide lockdown restrictions last week and announced the national football league would restart in late June.

Critics have cast doubt on Russia's low official mortality rate, accusing authorities of under-reporting in order to play down the scale of the crisis.

Russian health officials say one of the reasons the count is lower is that only deaths directly caused by the virus are being included.

Deputy Prime Minister Tatiana Golikova over the weekend denied manipulation of numbers, saying hospitals had a financial interest in identifying infections because they are allocated more money to treat coronavirus patients.

Authorities also say that since the virus came later to Russia, there was more time to prepare hospital beds and launch wide-scale testing to slow the spread.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.